Therefore, the developed combined immunotherapy mediated by vaccine nodules can effectively improve and penetrate tumor CD8+ T cells, inhibit the tumor immunosuppressive environment, and ultimately have good preventive and antitumor effects. This evidence concerns the gene CD8A and neoplasm.